White label – Pompe disease - ClinicalTrials.eu

Study of alpha-1 antitrypsin given intravenously to hospitalized patients during COPD exacerbation

Recruiting

2 1 1
Investigated Diseases:
- Chronic obstructive pulmonary disease
Investigated Drugs:
- Human Alpha1-Proteinase Inhibitor
- Sodium Chloride
Study on Dupilumab and Fexofenadine for Treating Indolent Systemic Mastocytosis with Skin Involvement in Patients

Recruiting

3 1 1
Investigated Diseases:
- Systemic mastocytosis
Investigated Drugs:
Study of Gadobutrol for MRI in Adults with Cerebrospinal Fluid Disorders, Including Hydrocephalus and Brain Tumors

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Gadobutrol
Study of Danicopan with Ravulizumab or Eculizumab for Children with Paroxysmal Nocturnal Hemoglobinuria and Extravascular Hemolysis

Recruiting

3 1 1
Investigated Diseases:
- Paroxysmal nocturnal haemoglobinuria
Investigated Drugs:
- Danicopan
Study on the Effectiveness and Safety of AZD0486 for Adults with Relapsed or Refractory Non-Hodgkin Lymphoma

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

Recruiting

3 1 1 1
Investigated Diseases:
- Staphylococcal bacteraemia
Investigated Drugs:
Study of TIL therapy combined with peginterferon alfa-2a and nivolumab for patients with metastatic melanoma

Recruiting

1 1 1 1
Investigated Diseases:
- Metastatic malignant melanoma
Investigated Drugs:
- TIL CELLS
- Zirconium (89Zr) Crefmirlimab Berdoxam
Study on Virus-Specific T-Cells for Treating Resistant Viral Infections in Young Patients After Stem Cell Transplant

Recruiting

1 1 1
Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

Recruiting

3 1 1 1
Investigated Diseases:
- Relapsing multiple sclerosis
Investigated Drugs:
Study of Atezolizumab, Paclitaxel, and Carboplatin for Patients with Stage IIIA and IIIB Non-Small Cell Lung Cancer

Recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies